The Indiana Biotechnology Manufacturing Hub
Indiana is accelerating biotechnology, bioinnovation, and advanced manufacturing in plant, animal, and human health.
Indiana leads the nation in pharmaceutical exports
Indiana is the only state in the nation to manufacture all three COVID-19 vaccines
One of the top three states in exports for all life sciences products – pharmaceuticals, medical devices, and agbiosciences — for more than a decade
Why Indiana?
The COVID-19 pandemic exposed America’s supply chain vulnerability and reliance on the off-shore manufacturing of life sciences products. Indiana is home to pioneers in human, plant, and animal health – all of which are essential to the nation’s ability to care for and feed its people. Future advances in each of these critical sectors will center on the core sciences found in biological product development – the process of building new biomolecular products and the further development of nascent modalities. These interrelated pathways must innovate in parallel. Currently, the research to rapidly advance manufacturing capability is too reliant on an ecosystem of decentralized innovation.
With a focused investment in the Indiana biotechnology manufacturing ecosystem, the Economic Development Administration can tether together disconnected capabilities to expedite the creation of a sector-agnostic biotechnology manufacturing hub in the densest advanced manufacturing state in the nation on a per capita basis. The central concentration of global behemoths like Eli Lilly, Corteva, and Elanco, alongside world-class R1 research institutes like Indiana University, Purdue University, and the University of Notre Dame, make Indiana a prime location to spur next-generation innovation and mitigate the national security risks currently posed by the United States’ over-reliance on off-shore life sciences manufacturing.
1,116
In Indiana, 1,116 life sciences new patents were granted in 2022
43 new products were approved by the U.S. Food and Drug Administration
43

Indiana University School of Medicine is the largest medical school in the country with more than 1,400 medical students.

BioCrossroads is Indiana’s initiative to grow the life sciences, a public-private collaboration that supports the region’s research and corporate strengths while encouraging new business development.

Purdue University features the nation’s top graduate Agricultural & Biological Engineering program for 11 years straight, according to U.S. News & World Report.
$77 Billion
Economic output of the state’s life science industry was $77 billion driven by more than 2,700 companies.
2,700
Increase in the number of companies in 2022 over 2021.
9%